# Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin

> **NCT06440473** · PHASE4 · RECRUITING · sponsor: **Rao Dermatology** · enrollment: 3 (estimated)

## Conditions studied

- Healthy Skin

## Interventions

- **DRUG:** Roflumilast
- **OTHER:** Vehicle (Roflumilast 0.3% vehicle cream)

## Key facts

- **NCT ID:** NCT06440473
- **Lead sponsor:** Rao Dermatology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-28
- **Primary completion:** 2024-06-28
- **Final completion:** 2024-07-28
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2024-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06440473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06440473, "Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06440473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*